Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This is a Phase 2 study in adult participants with moderate to severe hidradenitis suppurativa (HS). The purpose of the study is to evaluate the efficacy and safety of SAR442970 compared to placebo.
Full description
The study duration will be up to 40 weeks.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
The above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.
Primary purpose
Allocation
Interventional model
Masking
86 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Trial transparency email recommended (Toll free for US & Canada
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal